PubMed:27149136 / 3825-3978 JSONTXT

Annnotations TAB JSON ListView MergeView

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T34","span":{"begin":0,"end":153},"obj":"Sentence"},{"id":"T34","span":{"begin":0,"end":153},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Two years after the diagnosis he continues with bicalutamide treatment, prednisone 5 mg q.a.d. and has residual toughening of the skin on his lower legs."}

    Inflammaging

    {"project":"Inflammaging","denotations":[{"id":"T34","span":{"begin":0,"end":153},"obj":"Sentence"},{"id":"T34","span":{"begin":0,"end":153},"obj":"Sentence"}],"text":"Two years after the diagnosis he continues with bicalutamide treatment, prednisone 5 mg q.a.d. and has residual toughening of the skin on his lower legs."}

    UBERON-AE

    {"project":"UBERON-AE","denotations":[{"id":"PD-UBERON-AE-B_T22","span":{"begin":148,"end":152},"obj":"http://purl.obolibrary.org/obo/UBERON_0000978"}],"text":"Two years after the diagnosis he continues with bicalutamide treatment, prednisone 5 mg q.a.d. and has residual toughening of the skin on his lower legs."}

    performance-test

    {"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T10","span":{"begin":148,"end":152},"obj":"http://purl.obolibrary.org/obo/UBERON_0000978"}],"text":"Two years after the diagnosis he continues with bicalutamide treatment, prednisone 5 mg q.a.d. and has residual toughening of the skin on his lower legs."}